Cargando…

A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list

BACKGROUND: Globally, cardiovascular disease (CVD) is a leading cause of death and disproportionately affects low- and middle-income countries (LMICs). The WHO Model List of Essential Medicines (WHO EML) is a tool for improving accessibility and availability of medicines. This study compared the 202...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naicker, Ian, Suleman, Fatima, Perumal-Pillay, Velisha Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733348/ https://www.ncbi.nlm.nih.gov/pubmed/36482421 http://dx.doi.org/10.1186/s40545-022-00494-0

Ejemplares similares

Quantitative evaluation of essential medicines lists: the South African case study
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2016)

Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2017)

Drawing lessons from the standard treatment guidelines and essential medicines list concept in South Africa as the country moves towards national health insurance
por: Perumal-Pillay, Velisha A., et al.
Publicado: (2021)

Evaluating the implementation of the standard treatment guidelines (STGs) and essential medicines list (EML) at a public South African tertiary institution and its associated primary health care (PHC) facilities
por: Govender, Tashni, et al.
Publicado: (2021)

Understanding the decision making process of selection of medicines in the private sector in South Africa – lessons for low-middle income countries
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2020)

Parents’ and guardians’ perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa – a qualitative study
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2017)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
por: Maraj, Darshanand, et al.
Publicado: (2022)

Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019)

Challenges in updating national guidelines and essential medicines lists in Sub‐Saharan African countries to include WHO‐recommended postpartum hemorrhage medicines
por: Ng'ang'a, Joyce, et al.
Publicado: (2022)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

Perceptions from pharmaceutical stakeholders on how the pharmaceutical budget is allocated in South Africa
por: Moodley, Lirosha, et al.
Publicado: (2021)

Extending Pharmacist Roles in Primary Healthcare to Meet the Needs of Universal Health Coverage in Zimbabwe: A Pharmacist Perspective and Curriculum Evaluation
por: Chiutsi, Douglas, et al.
Publicado: (2022)

The availability of priority medicines for children under 5 years in eThekwini, South Africa
por: Mahadeo, Shannice, et al.
Publicado: (2022)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa
por: Bojuwoye, Adetola Olaniyi, et al.
Publicado: (2022)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
por: Husain, Muhammad Jami, et al.
Publicado: (2020)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Correction to: Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
Publicado: (2020)

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Biologic medicine inclusion in 138 national essential medicines lists
por: Kraus, Raphaël, et al.
Publicado: (2021)

The case for levetiracetam to be included in essential medicine lists
por: Singh, Gagandeep, et al.
Publicado: (2023)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
por: Cappello, Bernadette, et al.
Publicado: (2020)

Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
por: Jeličić Kadić, Antonia, et al.
Publicado: (2014)

National List of Essential Medicines, 2015: Endocrinology perspective
por: Kalra, Sanjay
Publicado: (2016)

A comparison of national essential medicines lists in the Americas
por: Steiner, Liane, et al.
Publicado: (2020)

Indian Essential Medicine List for Children: Time to Revisit
por: Singhal, Shubha, et al.
Publicado: (2023)

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
por: Peacocke, Elizabeth F., et al.
Publicado: (2022)

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
por: Zhou, Yue, et al.
Publicado: (2023)

Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
por: delMoral-Sanchez, Jose-Manuel, et al.
Publicado: (2020)

WHO essential medicines for reproductive health
por: Gill, Roopan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_adcc3tprc83uns5u2tfkhti3u5